An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

NCT06079567 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Facioscapulohumeral Muscular Dystrophy Type 2

Interventions

DIAGNOSTIC_TEST: Validation of new COMs for FSHD2 patients

Sponsor

Centre Hospitalier Universitaire de Nice